The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Breast Cancer Survivorship, Quality of Life, and Late Toxicities
Open accessAbstract
Breast cancer is the most frequent cancer in women: in 2018, almost two million cases have been diagnosed all over the world and it represents the principal cause of death from a neoplastic disease in women. In the past years, breast cancer prognosis has significantly improved over time: currently 5-year survival rates are in the range of 90%, and 10-year survival is about 80%. This improvement has been mostly observed in western countries, due to high coverage and compliance with screening programs, leading to early diagnosis, i.e., when the disease is at a subclinical level, and to an improvement in tumor molecular characterization and innovative systemic treatments. Yet the identification of different biological breast cancer subtypes prompted the development of innovative targeted agents and improved treatment personalization. On the other hand, longer survival rates and increasing proportions of cured patients require dedicated strategies to manage long-term sequelae of breast cancer treatments, with particular attention to quality of life. This review analyzes the most important issues, potentially occurring with cancer treatments, concerning long-term sequelae and quality of life, to define a global approach to breast cancer survivorship.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to somatic side effects of the therapy, such as neurotoxicity and cardiotoxicity, lymphoedema or pain [6–8], increased tumour-related stress or mental illnesses such as anxiety and depression play a central role in follow-up care.”
From The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial (2024) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Zamorano, J. L., Lancellotti, P., Muñoz, D. R., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw211 · Cited by 2,639
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L. D., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,456
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
Swain, S. M., Baselga, J., Kim, S.-B., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J.-M., Schneeweiss, A., Heeson, S., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1413513 · Cited by 2,164
Baum, M., Budzar, A. U., Cuzick, J. M., Forbes, J., Houghton, J., Klijn, J. G. M., & Sahmoud, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09088-8 · Cited by 1,958
Zamorano, J. L., Lancellotti, P., Muñoz, D. R., Aboyans, V., Asteggiano, R., Galderisi, M., Habib, G., Lenihan, D. J., Lip, G. Y. H., Lyon, A. R., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.654 · Cited by 1,800
Sledge, G. W., Toi, M., Neven, P., Sohn, J., Inoue, K., Pivot, X., Burdaeva, O., Okera, M., Masuda, N., Kaufman, P. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.7585 · Cited by 1,680
Overall survival with ribociclib plus endocrine therapy in breast cancer
Im, S.-A., Lu, Y.-S., Bardia, A., Harbeck, N., Colleoni, M., Franke, F., Chow, L., Sohn, J., Lee, K.-S., Campos-Gomez, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903765 · Cited by 1,001
Piccart, M., Hortobagyi, G. N., Campone, M., Pritchard, K. I., Lebrun, F., Ito, Y., Noguchi, S., Perez, A., Rugo, H. S., Deleu, I., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu456 · Cited by 574
Cardiotoxicity of anticancer treatments
Ewer, M. S., & Ewer, S. M. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.65 · Cited by 436
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 330
Georgopoulou, S., Droney, J., Jaganathan, P. P., Howell, P., Doherty, A. M., Young, K., & Cruickshank, S. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102862 · Cited by 6
Konieczny, M., Sawicka, J., Gąska, I., Kaczmar, E., Babuśka–Roczniak, M., & Bądziul, D. (2025) · Cancers · doi:10.3390/cancers17030497 · Cited by 6
Cheang, I., Gue, Y. X., Wu, M., Huang, J., Ren, Q. W., Chen, Z., Tse, Y.-K., Li, H., Chan, Y., Tse, H., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-14280-z · Cited by 6
Evaluation of aesthetic flat closure: A scoping review
Bhaskara, M. C., Hulsman, L., Ahmed, S., Sidhu, A. S., Fathauer, C., Rinne, E., Ludwig, K. K., Lester, M. E., Hadad, I., Fisher, C. S., et al. (2025) · JPRAS Open · doi:10.1016/j.jpra.2025.08.024 · Cited by 6
Sahar, O., Zvi, R. H., Barsuk, D., Barnea, Y., Pridan, O. G., Hod, K., & Ben-David, M. A. (2024) · Aesthetic Surgery Journal · doi:10.1093/asj/sjae030 · Cited by 6
Shimomura, A., Sagara, Y., Koto, R., Fujiwara, M., Kanemura, Y., Kitagawa, H., & Saji, S. (2024) · Breast Cancer · doi:10.1007/s12282-024-01572-8 · Cited by 7
Zhang, N., Sun, L., Chen, X., Song, H., Wang, W., & Sun, H. (2024) · Journal of Clinical Ultrasound · doi:10.1002/jcu.23803 · Cited by 6
Srinivasan, M. K., Mohanprasanth, A., Nalini, N., & Saravanan, M. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156117 · Cited by 6
Lippi, L., Alessandro de, S. I. R. E., Folli, A., Maconi, A., Polverelli, M., Vecchio, C., Fusco, N., & Invernizzi, M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111833 · Cited by 6
Unmet Care Needs in Breast Cancer Survivors: An Integrative Review
Tabari-Khomeiran, R., Ahmadi, F., Jafaraghaee, F., Noveiri, M. J. S., & Mirfarhadi, N. (2023) · Journal of Holistic Nursing and Midwifery · doi:10.32598/jhnm.33.1.2272 · Cited by 6
Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase
Tinivella, A., Banchi, M., Gambacorta, G., Borghi, F., Orlandi, P., Baxendale, I. R., Paolo, A. D., Bocci, G., Pinzi, L., & Rastelli, G. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00183 · Cited by 6
Kong, L.-X., Zhao, Y.-H., Feng, Z.-L., & Liu, T. (2024) · World Journal of Psychiatry · doi:10.5498/wjp.v14.i6.876 · Cited by 6
Harerimana, A., & Mchunu, G. G. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03858-1 · Cited by 5
Kandzi, J. D., Englisch, A., Böer, B., Hahn, M., Wallwiener, M., Volmer, L. L., Brucker, S. Y., Hartkopf, A. D., & Engler, T. (2025) · Clinical Breast Cancer · doi:10.1016/j.clbc.2025.10.003 · Cited by 5
Wahab, R., Siddiqui, M. A., Ahmad, J., Saquib, Q., & Al-Khedhairy, A. A. (2023) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2023.102843 · Cited by 5
Cerulli, C., Moretti, E., Grazioli, E., Emerenziani, G. P., Murri, A., Tranchita, E., Minganti, C., di Cagno, A., & Parisi, A. (2024) · Bone Reports · doi:10.1016/j.bonr.2024.101756 · Cited by 5
Park, C. L., Magin, Z. E., Bellizzi, K. M., & Sanft, T. B. (2024) · Psycho-Oncology · doi:10.1002/pon.70040 · Cited by 5
Ma, T., Ma, T., Li, X., Sun, X.-Y., Cao, W., Niu, Z., & Wang, H. (2024) · World Journal of Surgical Oncology · doi:10.1186/s12957-024-03618-9 · Cited by 5
Liposomal oncolytic adenovirus as a neoadjuvant therapy for triple-negative breast cancer
Shah, J. R., Dong, T., Phung, A. T., Khan, S., Aisagbonhi, O. A., Blair, S. L., Bouvet, M., Trogler, W. C., & Kummel, A. C. (2025) · Scientific Reports · doi:10.1038/s41598-025-00211-2 · Cited by 5
Borg, M. B., Mittino, L., Battaglia, M., Loro, A., Lanzotti, L., Invernizzi, M., & Baricich, A. (2023) · Cancers · doi:10.3390/cancers15020426 · Cited by 5
Cognitive function is mediated by deficit accumulation in older, long-term breast cancer survivors
Ahles, T. A., Schofield, E., Li, Y., Ryan, E., Orlow, I., Patel, S. K., Traina, T. A., & Root, J. C. (2023) · Journal of Cancer Survivorship · doi:10.1007/s11764-023-01365-6 · Cited by 5
Alsabry, A., Algabri, M. N. A., & Ahsan, A. M. (2023) · مجلة جامعة صنعاء للعلوم التطبيقية والتكنولوجيا · doi:10.59628/jast.v1i2.361 · Cited by 6
Curtit, E., Bellanger, M. M., Nerich, V., Héquet, D., Frenel, J., Cristeau, O., & Rouzier, R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1191943 · Cited by 5
PLLA Porous Scaffold as a 3D Breast Cancer Model to Investigate Drug Resistance
Carbone, C., Rigogliuso, S., Brucato, V., Cusimano, A., Labbozzetta, M., Carrubba, V. L., Poma, P., Notarbartolo, M., & Pavia, F. C. (2024) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37836 · Cited by 5
Mechanisms and benefits of phytochemicals as an alternative therapeutic strategy in female cancers
Zhao, Y., Deng, S., Cao, D., Lin, C., Xu, M., Wang, J., Luo, L., Liu, S., & Liu, H. (2025) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2025.04.002 · Cited by 5
Jang, M. K., Kim, S. H., Ko, Y. H., Han, J., Kim, S. Y., & Kim, S. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221085491 · Cited by 5
Nikolaeva, A. E., Pospelova, M. L., Krasnikova, V. V., Makhanova, A. M., Tonyan, S. N., Krasnopeev, Y., Kayumova, E., Vasilieva, E. Y., Efimtsev, A. Y., Levchuk, A. G., et al. (2023) · Pathophysiology · doi:10.3390/pathophysiology30020022 · Cited by 5
Elsabeeny, W. Y., Fahmy, R. M., Elshamy, F. H., Shehab, N. N., Abed, S. M., Taha, W. S., Ibrahim, M. A., & Gad, A. F. (2025) · PAIN Reports · doi:10.1097/pr9.0000000000001234 · Cited by 4
Molfino, A., Imbimbo, G., Pisegna, S., Scagnoli, S., Alabiso, C., Ardovino, M., Gallicchio, C., Rizzo, V., & Botticelli, A. (2025) · Cancers · doi:10.3390/cancers17183063 · Cited by 4
Rethorst, C. D., Carmody, T. J., Argenbright, K. E., Vazquez, L., DeLuca, T., Mayes, T. L., Hamann, H. A., & Trivedi, M. H. (2024) · Journal of Behavioral Medicine · doi:10.1007/s10865-024-00518-x · Cited by 5
Malcolm, J. R., Bridge, K. S., Holding, A. N., & Brackenbury, W. J. (2025) · BMC Genomics · doi:10.1186/s12864-025-11216-6 · Cited by 4
Preference reversals in ethicality judgments of medical treatments
Lemli, B. A., & Landy, J. F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319233 · Cited by 4
Tabei, P., Molazem, Z., Rivaz, M., Ghaemmaghami, P., & Ahmadloo, N. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-05052-0 · Cited by 4
Pantiora, E. V., Hedman, L. C., Aristokleous, I., Sjökvist, O., Karakatsanis, A., & Schiza, A. (2023) · International Journal of Surgery · doi:10.1097/js9.0000000000000815 · Cited by 4
Future of autologous breast reconstruction: a review of novel technological innovations
Allam, O., Foster, C. E., Knoedler, L., Knoedler, S. A., Oh, S. J., Pomahač, B., & Ayyala, H. S. (2024) · Plastic and Aesthetic Research · doi:10.20517/2347-9264.2024.21 · Cited by 4
Kang, Z., Jin, Y., Yu, H., Su, L., & Qi, Y. (2024) · BMC Cancer · doi:10.1186/s12885-024-12478-1 · Cited by 4
Cardador, C. M., de Castro, T. B., de Castro, R. J. A., Bocca, A. L., Camargo, L. C., Pacheco, T. J. A., Muehlmann, L. A., & Longo, J. P. F. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128316870240610045550 · Cited by 4
Financial burden of lymphedema among breast cancer survivors in Iran: A qualitative study
Yarmohammadi, H., Soltanipur, M., Farahani, M. S., Hosseini, S. E., & Sheikhi, Z. (2024) · JMV-Journal de Médecine Vasculaire · doi:10.1016/j.jdmv.2024.09.001 · Cited by 4
Health Information on Breast Cancer Surgery on YouTube®
Cousins, L., Darragh, L., & Kerr, B. (2025) · Clinical Breast Cancer · doi:10.1016/j.clbc.2025.01.003 · Cited by 4
Camargo, L. C., Burgel, P., Cardador, C. M., da Silva, V. C. M., Paiva, K. L. R., Simões, M. M., de Castro, R. J. A., Valente, I. M., Farias, G. R., de Castro, T. B., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118079 · Cited by 4
Qi, W., Cao, L., Xu, C., & Chen, J. (2021) · Journal of Oncology · doi:10.1155/2021/2497227 · Cited by 4
Robertson, M. C., Cox-Martin, E., Basen-Engquist, K. M., & Lyons, E. (2024) · JMIR mhealth and uhealth · doi:10.2196/51057 · Cited by 4
Mallah, S. H., Jabir, F. A., & Al-Askeri, M. A. A. (2024) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2024.25.3.1007 · Cited by 4
Al-Awadhi, A. M., Iqbal, F., Kourié, H. R., & Al-Shamsi, H. O. (2024) · Springer eBooks · doi:10.1007/978-981-99-6794-0_26 · Cited by 4
Best timing for exercise in breast cancer patients initiating chemotherapy: what is the answer?
Abreu, A. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad136 · Cited by 4
Schäfer, A., Wendel, J., Franke, I., Bauer, A., Baumeister, H., Bendig, E., Brucker, S. Y., Deutsch, T. M., Garatva, P., Haas, K., et al. (2024) · Trials · doi:10.1186/s13063-024-08614-8 · Cited by 3
Merrill, R. M., & Gibbons, I. S. (2024) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-024-02079-w · Cited by 3
Unraveling the microbiome’s role in breast cancer progression and treatment response
Taki, . G., Shareef, A., Arora, V., Oweis, R. J., Jyothi, S. R., Singh, U., Sahoo, S., Chauhan, A. S., Alimova, F., Sameer, H. N., et al. (2025) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2025.101264 · Cited by 3
Silva, A., Dupuis, K.-L., Pourrajabi, A., Kulawic, K., Galica, J., Teggart, K., Abolhasani, R., Lino, M., Schumacher, C., Hayward, S., et al. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10627-9 · Cited by 3
Encabo, P. G., Wilson, R. L., Kang, D., Norris, M. K., Uno, H., Christopher, C. N., Chow, C. R., Sami, N., Fox, F., Ligibel, J. A., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.864844 · Cited by 3
Stakeholders’ Experiences and Perspectives Regarding Care Quality for Women With Breast Cancer
Kasgari, K. A., Sany, S. B. T., Mahdizadeh, M., Tehrani, H., Charati, J. Y., & Peyman, N. (2022) · Cancer Nursing · doi:10.1097/ncc.0000000000001119 · Cited by 3
Svee, A., Sjökvist, O., Unukovych, D., Gümüscü, R., Moradi, M., Falk-Delgado, A., & Mani, M. R. (2024) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000006011 · Cited by 3
Abd-Elrasheed, E., Fahim, S. A., Nessim, C. K., & El-Helaly, S. N. (2024) · Scientific Reports · doi:10.1038/s41598-024-78422-2 · Cited by 3
Marshall, A., Donnelly, P., Elbeltagi, N. I., Gasson, S. J., Broadfield, A., Hopkins, A., Hartup, S. M., Turner, L., Young, A., Watson, E. K., et al. (2025) · Health and Quality of Life Outcomes · doi:10.1186/s12955-025-02396-6 · Cited by 3
Quality of life in long-term cancer-free breast cancer survivors in spain: A descriptive study
Soto‐Ruiz, N., Escalada‐Hernández, P., Parra, G., & García‐Vivar, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-10176-x · Cited by 5
Bouhenni, H., Zehravi, M., Reza, F., Sweilam, S. H., Arjun, U. V. N. V., Shanmugarajan, T. S., Mahesh, P. G., Durairaj, A., Jahnavi, P., Natarajan, V., et al. (2025) · Medical Oncology · doi:10.1007/s12032-025-02792-4 · Cited by 3
Vezzani, F., Cabieses, B., V, Alexandra Obach, K., Torrealba, S., & Carvajal, I. (2025) · PLoS ONE · doi:10.1371/journal.pone.0330166 · Cited by 3
Mendes-Santos, C. (2021) · Linköping studies in arts and science · doi:10.3384/9789179291143 · Cited by 3
Quantifying Societal Burden of Radiation-Induced Cardiovascular Events in Breast Cancer Survivors
Kimpe, E., Werbrouck, A., Ridder, M. D., & Putman, K. D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.869529 · Cited by 3
Daifallah, A., Salameh, H. T., Suwan, B. A., Rabayaa, M., Khayyat, Z., Hasoon, M., Nazzal, M. A., Al‐Jabi, S. W., & Zyoud, S. H. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07981-3 · Cited by 3
Pérez, A. M. L., Collado‐Mateo, D., Hinojo, C., Ferré, A. D. J., Villar, C. R., Mayo, X., & Jiménez, A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1231683 · Cited by 3
Empowering breast cancer survivors: Nurturing self-compassion for a positive body image
Pandey, P., & Gogia, A. (2023) · Cancer Research Statistics and Treatment · doi:10.4103/crst.crst_303_23 · Cited by 3
Haesen, S., Verghote, E., Heeren, E., Wolfs, E., Deluyker, D., & Bito, V. (2024) · Cells · doi:10.3390/cells13020120 · Cited by 3
Towards Agility in Breast Cancer Treatment Principles as Adopted from Agile Software Engineering
Odeh, Y., & Al-Balas, M. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s449465 · Cited by 3
Manolitsis, I. S., Feretzakis, G., Tzelves, L. I., Αναστασίου, Α., Koumpouros, Y., Verykios, V. S., Katsimperis, S. N., Bellos, T. C., Lazarou, L. C., & VARKARAKIS, I. M. (2024) · Healthcare · doi:10.3390/healthcare12181817 · Cited by 3
Huang, W., Qiu, Z.-K., Mu, T., & Li, X. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.923554 · Cited by 3
Unplanned implant removal in locally advanced breast cancer
Anderson, J. D., Hammond, J. B., Kosiorek, H., Thorpe, C. S., Bhangoo, R. S., Pockaj, B. A., Gray, R. J., Cronin, P. A., Rebecca, A. M., Casey, W. J., et al. (2021) · The Breast Journal · doi:10.1111/tbj.14224 · Cited by 3
(2023) · Journal of Population Therapeutics and Clinical Pharmacology · doi:10.47750/jptcp.2023.30.05.030 · Cited by 2
Ho, P. J., Lim, E. H., Riza, N. K. M., Hartman, M., Wong, F. Y., & Li, J. (2023) · Cancers · doi:10.3390/cancers15092559 · Cited by 2
Orellana-Jaén, J., Mora-Fernández, M., & Páez, L. C. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107672 · Cited by 2
Al-Shamsi, H. O., & Abyad, A. M. (2024) · Springer eBooks · doi:10.1007/978-981-99-6794-0_2 · Cited by 2
Ashi, A., Awaji, A. A., Bond, J., Johnson, C. A., Shaaban, A. M., & Bell, S. M. (2025) · Histopathology · doi:10.1111/his.15399 · Cited by 2
Liu, H., Zheng, R., Zhuang, Z., Xue, L., Chen, M., Wu, Y., & Zeng, Y. (2025) · Cancer Management and Research · doi:10.2147/cmar.s502155 · Cited by 2
Prediction of Breast Cancer Remission
Cardenas, V., Li, Y., Shrestha, S., & Xue, H. (2025) · Quality Management in Health Care · doi:10.1097/qmh.0000000000000513 · Cited by 2
Marino, G., Pace, G., Sabato, L., Sichetti, M., & Mecca, M. (2025) · Nutrients · doi:10.3390/nu17152506 · Cited by 2
Borrego, E. A., Pérez, J. L. G., Esparza, A., Delgado, P., Moreno, K., Poon, W., Chambers, D., Joddar, B., & Natividad-Diaz, S. L. (2025) · Discover Applied Sciences · doi:10.1007/s42452-025-07523-y · Cited by 2
Cardiovascular diseases in the long-term after surviving malignant neoplasms: A review
Poltavskaya, M. G., Игоревна, Н. А., & Bezlyudskiy, A. L. (2025) · Consilium Medicum · doi:10.26442/20751753.2025.8.203064 · Cited by 2
Soto‐Ruiz, N., Parra, G. A. P., Escalada‐Hernández, P., & García‐Vivar, C. (2025) · JMIR Cancer · doi:10.2196/76719 · Cited by 5
Sattari, P., Shakourifar, M., Jafarian, K., Naghsh, E., Sadeghi, A., Sharifi, M., & Moghaddas, A. (2025) · Advanced Biomedical Research · doi:10.4103/abr.abr_352_22 · Cited by 2
Bahardoust, M., Yarahmadi, D., Rad, F. N., Mehdikakoienejad, M., Kazemi, B., Goodarzy, B., & Tizmaghz, A. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01967-7 · Cited by 2
Hu, L., Chau, P. H., Wu, C., & Choi, E. P. H. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-10250-0 · Cited by 2
Polyunsaturated fatty acids in the prevention, treatment, and survival of breast cancer
Vinka, L., Jesús, V. M., Reyes, C., Sánchez, C. J. M., Rodrigo Valenzuela, B., & Camila, F. (2026) · Nutrition · doi:10.1016/j.nut.2026.113311 · Cited by 2
Wang, Y., Liang, X., Wang, S., Wang, Y., Qin, L., Chen, D., Jiang, Y., & Zhang, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.772726 · Cited by 2
Niu, J., Chen, D., Lo, C., Cheng, S., & Huang, C. (2022) · Cancer Control · doi:10.1177/10732748221132522 · Cited by 2
Rabah, N. M., Jarmula, J., Hamza, O., Khan, H. A., Chakravarthy, V., Habboub, G., Wright, J. M., III, Steinmetz, M. P., Wright, C. H., & Krishnaney, A. A. (2023) · Neurosurgery · doi:10.1227/neu.0000000000002348 · Cited by 2
Awaluddin, A., Pieter, J., Sampepajung, E., Syamsu, S. A., Smaradhania, N., Hamid, F., Prihantono, P., LAIDDING, S. R., Kusuma, M. I., & Faruk, M. (2023) · Breast Disease · doi:10.3233/bd-239000 · Cited by 2
The relationship between coping self-efficacy and B cells in breast cancer patients
Elamir, A. M., EL-Baiomy, E., Sabry, N. A., Kassem, L. M. H., Chesney, M. A., & Wallston, K. A. (2023) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-023-00187-y · Cited by 2
Helwani, A. M., Suleimani, Y. M. A., Al-Baimani, K. S., & Abdelrahman, A. M. (2023) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552231214467 · Cited by 2
Kuang, X., Lin, L., Yuan, H., Zhao, L., & He, T. (2024) · Oncology Letters · doi:10.3892/ol.2024.14231 · Cited by 2
Hong, Y. J., Han, K., Lee, H., Hur, J., Kim, Y. J., Kim, M. J., & Choi, B. W. (2024) · Radiology Cardiothoracic Imaging · doi:10.1148/ryct.220229 · Cited by 2
Salman, Z. O., Alwash, B. M. J., & Kadhim, E. J. (2024) · Baghdad Science Journal · doi:10.21123/bsj.2024.9276 · Cited by 2
Hamilton, S., Oxlad, M., & Sianis, Y. (2024) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2024.2342836 · Cited by 4
Levkovich, I., Rosman, L., & Signorelli, C. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300396 · Cited by 2
Feighan, L., MacDonald‐Wicks, L. K., Callister, R., & Surjan, Y. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08933-1 · Cited by 3
Bao, F., Yu, L., Zhang, X., & Mu, Q. (2025) · PeerJ · doi:10.7717/peerj.18888 · Cited by 2
Huang, Y., Yu, Z., Wang, Y., Liu, Q., Zhao, K., & Feng, W. G. (2025) · Journal of Cancer Survivorship · doi:10.1007/s11764-025-01783-8 · Cited by 2
Targeting breast cancer: the promise of phage-based nanomedicines
Gholami, S., Saffarfar, H., Mehraban, M. R., Ardabili, N. S., Elhami, A., Ebrahimi, S., Ali‐Khiavi, P., Kheradmand, R., Fattahpour, S. F., & Mobed, A. (2025) · Breast Cancer Research and Treatment · doi:10.1007/s10549-025-07696-5 · Cited by 2
Goodman, W., Lally, P. J., Fisher, A., & Beeken, R. J. (2025) · Cancer Medicine · doi:10.1002/cam4.70885 · Cited by 2
Nielsen, A., Marstrand, S. D., Marina, D., Andersson, M., Jensen, L. T., Buch‐Larsen, K., & Schwarz, P. (2025) · Cancer Investigation · doi:10.1080/07357907.2025.2510996 · Cited by 2
HER2-Targeted Nanoliposome Therapy Activates Immune Response by Converting Cold to Hot Breast Tumors
Sun, Q., Zhu, Y., Zhao, D., Yang, L., Zhang, S., & Huang, C. (2025) · Technology in Cancer Research & Treatment · doi:10.1177/15330338251356387 · Cited by 2
Metadata
- Authors
- Nardin, S., Mora, E., Varughese, F. M., D'Avanzo, F., Vachanaram, A. R., Rossi, V., Saggia, C., Rubinelli, S., & Gennari, A.
- Affiliations
- Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
- Azienda Ospedaliero Universitaria Maggiore della Carita (IT)
- Corresponding author
- Gennari, Alessandra
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2020-06-16
- Volume
- 10
- Pages
- 864-864
- ISSN
- 2234-943X (ISSN-L)
- PMC
- PMC7308500
- OpenAlex
- W3036457113
- Cited by
- 330
- References
- 39
- Citations by year
- 2026: 47 · 2025: 85 · 2024: 83 · 2023: 55 · 2022: 37 · 2021: 21 · 2020: 2
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Keywords
- breast cancer survivorship, quality of life, late toxicity, breast cancer screening, breast cancer subtypes, targeted therapy, personalized treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
